RECENT TRENDS IN MODIFIED TRANSDERMAL PATCHES
DOI:
https://doi.org/10.47957/ijciar.v9i1.212Keywords:
Transdermal drug delivery, Microneedle patches, Nanotechnology-based carriers, Smart responsive patches, Controlled drug release, Personalized medicineAbstract
Transdermal drug delivery has emerged as a promising alternative to oral and injectable routes, offering non-invasive, convenient, and controlled drug administration. Modified transdermal patches enhance traditional systems by incorporating technologies such as microneedles, iontophoresis, nano-carriers, and smart responsive materials. These innovations improve drug permeation, bioavailability, and therapeutic efficiency while minimizing systemic side effects. Recent trends focus on delivering a wider range of drugs, including hormones, peptides, proteins, vaccines, and small molecules. Microneedle-based patches allow painless administration of macromolecules previously unsuitable for transdermal delivery. Nanotechnology integration improves solubility, stability, and controlled release of drugs. Smart patches with sensors nable real-time monitoring and personalized drug release for chronic diseases like diabetes and cardiovascular disorders. Current research emphasizes customization, patient adherence, and long-term therapy effectiveness. Transdermal systems now target neurological, psychiatric, dermatological, and immunotherapeutic applications. Clinical studies demonstrate improved pharmacokinetics Advanced fabrication techniques, including 3D printing.
Downloads
References
Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261–1268. DOI: https://doi.org/10.1038/nbt.1504
Guy RH. Current status and future prospects of transdermal drug delivery. Pharm Res. 2010;27(1):1–9.
Brown MB, Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems. Drug Deliv. 2006;13(3):175–187. DOI: https://doi.org/10.1080/10717540500455975
Ita K. Transdermal delivery of drugs with microneedles: potential and challenges. Pharmaceutics. 2015;7(3):90–105. DOI: https://doi.org/10.3390/pharmaceutics7030090
Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010;17(4):187–207. DOI: https://doi.org/10.3109/10717541003667798
Karande P, Jain A, Mitragotri S. Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol. 2004;22(2):192–197. DOI: https://doi.org/10.1038/nbt928
Barry BW. Breaching the skin's barrier to drugs. Nat Biotechnol. 2004;22(2):165–167. DOI: https://doi.org/10.1038/nbt0204-165
Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128–137. DOI: https://doi.org/10.1016/j.addr.2012.09.032
Prausnitz MR. Engineering microneedle patches for vaccination and drug delivery to skin. Annu Rev Chem Biomol Eng. 2017;8:177–200. DOI: https://doi.org/10.1146/annurev-chembioeng-060816-101514
Benson HAE. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv. 2005;2(1):23–33. DOI: https://doi.org/10.2174/1567201052772915
Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004;56(5):619–658. DOI: https://doi.org/10.1016/j.addr.2003.10.026
Gupta R, Rai B. Transdermal patches: a review. Int J Pharm Sci Rev Res. 2014;24(1):99–106.
Singh J, Tripathi KP, Sakia TR. Effect of penetration enhancers on the in vitro transport of ephedrine through rat skin. Int J Pharm. 1993;99(1):53–61.
Trommer H, Neubert RHH. Overcoming the stratum corneum: the modulation of skin penetration. Skin Pharmacol Physiol. 2006;19(2):106–121. DOI: https://doi.org/10.1159/000091978
Published
How to Cite
Issue
Section
Citations
This work is licensed under a Creative Commons Attribution 4.0 International License.
